X4 Pharmaceuticals

XFOR

Börsenwert 328 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	4 Mio. $	–	–	–
2	2 NEA Management Company Timonium, Maryland	3,54 Mio. $	–	–	–
3	3 BlackRock New York	2,7 Mio. $	+169.713 $	+12.322	+3 %
4	4 Vanguard Group Malvern, Pennsylvania	1,9 Mio. $	-61.236 $	-4.446	-2 %
5	ACA 5 Acorn Capital Advisors New York	1,75 Mio. $	–	–	–
6	KCM 6 Kingdon Capital Management New York	1,65 Mio. $	+947.128 $	+68.766	+42 %
7	7 OrbiMed New York	1,6 Mio. $	-163.901 $	-11.900	-5 %
8	8 UBS Group Zurich, Switzerland	1,19 Mio. $	+1,89 Mio. $	+137.137	+446 %
9	9 Geode Capital Management Boston, Massachusetts	855.794 $	+56.222 $	+4.082	+4 %
10	10 State Street Boston, Massachusetts	722.221 $	-1.019 $	-74	-0,1 %
11	11 Ensign Peak Advisors Salt Lake City, Utah	528.509 $	-142.690 $	-10.360	-12 %
12	12 Pale Fire Capital SE Prague, Czech Republic	481.160 $	+290.794 $	+21.113	+45 %
13	13 Susquehanna International Group Bala Cynwyd, Pennsylvania	404.802 $	-80.449 $	-5.841	-9 %
14	14 Northern Trust Chicago, Illinois	296.402 $	-47.614 $	-3.457	-8 %
15	15 CIBC World Market Toronto, Ontario, Canada	248.220 $	+482.062 $	+35.000	Neu
16	16 Axa Paris, France	163.382 $	-1,09 Mio. $	-79.368	-78 %
17	17 Point72 Asset Management Stamford, Connecticut	153.660 $	–	–	–
18	18 Morgan Stanley New York	134.751 $	+8.953 $	+650	+4 %
19	19 Charles Schwab San Francisco, California	113.833 $	+19.889 $	+1.444	+10 %
20	20 Bank of New York Mellon New York	81.497 $	–	–	–
21	21 Schonfeld Strategic Advisors New York	79.296 $	-485.464 $	-35.247	-76 %
22	22 Goldman Sachs New York	64.742 $	-93.548 $	-6.792	-43 %
23	23 Deutsche Bank Frankfurt Am Main Ge, Germany	64.230 $	–	–	–
24	24 Millennium Management New York	61.171 $	–	–	–
25	25 UBS O'Connor Chicago, Illinois	59.614 $	-464.501 $	-33.725	-80 %

X4 Pharmaceuticals XFOR Börsenwert 328 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 328 Mio. $